Skip to main content

Table 2 Distribution of genotypes and serum levels of vascular endothelial growth factor

From: The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

Genotype Polymorphism No. of patients % Mean ± SD (pg/ml) P*
−2578C/A CC 116 61.1 453.2 ± 278.8 0.606
  CA 63 33.2 520.0 ± 392.3  
  AA 11 5.8 523.9 ± 391.7  
−2489C/T CC 116 61.1 453.2 ± 278.8 0.117
  CT 60 31.6 478.4 ± 350.0  
  TT 14 7.4 724.0 ± 517.7  
−1498 T/C TT 116 61.1 453.2 ± 278.8 0.563
  TC 61 32.1 512.2 ± 400.7  
  CC 13 6.8 568.2 ± 324.9  
−634 G/C GG 54 28.4 889.7 ± 453.7 0.004
  GC 93 48.9 471.4 ± 222.6  
  CC 43 22.6 410.7 ± 222.6  
+936C/T CC 135 71.1 440.0 ± 292.0 0.722
  CT 45 23.7 495.5 ± 329.3  
  TT 10 5.3 502.6 ± 371.1  
+1612 G/A GG 139 73.2 472.4 ± 339.2 0.371
  GA 47 24.7 538.3 ± 295.9  
  AA 4 2.1 267.0 ± 159.3  
  1. *by Mann–Whitney.
  2. SD: standard deviation.